Material featured on this site may be reproduced free of charge in any format or media without requiring specific permission. This is subject to the material being reproduced accurately and not being used in a derogatory manner or in a misleading context. Where the material is being published or issued to others, the source must be prominently acknowledged. However, the permission to reproduce this material does not extend to any material on this site, which is identified as being the copyright of a third party. Authorisation to reproduce such material must be obtained from the copyright holders concerned.
Copyright Policy
News & Highlights
- Clarification on Alternative Methods in the Indian Pharmacopoeia
- Amendment List-08 to IP-2018
- MoU between Indian Pharmacopoeia Commission and British Pharmacopoeia
- Release of Guidance Document for Drafting and Formatting of Monographs for Indian Pharmacopoeia
- Dr. Rajeev Singh Raghuvanshi Joined as the Secretary-cum-Scientific Director of IPC on 16.02.2021
- Skill Development Programme (SDP) - 2021 on Pharmacovigilance for Medical Products through Webinar
- Application of DNA Barcoding in Indian Pharmacopoeia Monographs: Special Emphasis on Herbal and Phytopharmaceutical Drugs to be held on 4th March 2021(The last date of registration has been extended up to 3rd March 2021)
- CORRIGENDUM: Constitution of Expert Working Group-Nutraceuticals
- The draft for "General Notices on Phytopharmaceutcal Drugs" is being published by the Indian Pharmacopoeia Commission; the stakeholders are invited to provide their comments (if any), to lab.ipc@gov.in, on or before 28 February 2021.
- Amendments in monographs of Vaccines and Immunosera for Human Use, Blood and blood related products and Biotechnology Derived Therapeutic Products in IP 2018
- Inclusion of New general chapters related to Biotechnology Derived Therapeutic Products’ Monographs in IP 2018
- IPC-PvPI is organizing a "Training Programme on Pharmacovigilance of COVID-19 Vaccines-cum-CTP Meeting" for ADR Monitoring Centers under PvPI on Thursday, 7th January, 2021, from 2:00 PM to 4:00 PM.
- Interactive Webinar on Application of Silica in Pharmaceuticals (Analysis/Drug Delivery/Vaccine Purification) on Thursday, 7th January, 2021, from 3:30 PM to 5:30 PM
- Vacancy Advertisement 2020 for various posts at IPC by Direct Recruitment
- Vacancy Advertisement 2020 for various posts at IPC by Deputation
- IPC is organizing an "Interactive Webinar on Stability Testing of Drugs and Role of Excipients " via digital/virtual platform on December 10, 2020.
- Indian Pharmacopoeia Commission, Notice on Amendment List-07 to IP 2018
- Pledge Taking Ceremony for Celebration of Constitution Day, 2020 on 26.11.2020 in Indian Pharmacopoeia Commission, Ghaziabad.
- Indian Pharmacopoeia Commission is celebrating Constitution Day (Reading the Preamble)
- IBD Vaccine Draft Ammendment for stakeholders comments. Stakeholder's may provide comments within 45 days of upload of the amendments to lab.ipc@gov.in
- Rashtriya Ekta Diwas-2020 Pledge Taking Ceremony on 31st October, 2020
- NCC-MvPI, IPC is organizing a webinar on "Participation of Medical Device Manufacturers in Materiovigilance Programme of India (MvPI)" via digital/virtual platform on December 4, 2020.
- Interactive Webinar on Microbiological Quality Control of Pharmaceutical Products on November 5, 2020 from 3:30 PM to 5:30 PM
- Draft Amendment Heparin Sodium IP 2018 for Public Review and Comments. Stakeholder's may provide comments within 45 days of upload of the amendments to lab.ipc@gov.in
- Vacancy Circular for Various Posts at IPC Purely on Contractual basis through Manpower Resource Outsourcing Services Providing Agency.
- Skill Development Programme on Pharmacovigilance for Medical Products (PvM) through 5 Day Webinar (9th November – 13th November 2020)
- Newsletter Vol 9-10, Issue 29-30, 2019-2020
- Link for Technical Bid Opening via Web Conferencing Facility against Tender No. IPC/5519/2020-21
- Minutes of the Meeting related to Heparin Sodium IP 2018 monograph
- Minutes of the Meeting related to Heparin Sodium IP 2018 monograph
View All